Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Ottobock on its acquisition of Exoneural Network AB
Mandate

Vinge advises Ottobock on its acquisition of Exoneural Network AB

January 25, 2021 Employment and Benefits IT, Telecommunications and Outsourcing M&A Corporate Commercial Corporate Crime & Compliance

Vinge advises Ottobock, a portfolio company to EQT, on its acquisition of Exoneural Network AB a Swedish startup that has developed the so called Exopulse Mollii Suit.

The suit covers the entire body and uses electrostimulation to relax tense or spastic muscles which can improve the mobility for people with spastic diseases. Ottobock is an international medtech company and the acquisition is a step towards the expansion of its portfolio for promising neuro-orthotics.

Vinge’s team consisted of, among others, partner Christina Kokko, associates Stina Bengtsson, Jesper Lindvall and Annie Fällström (M&A), Sara Strandberg and Carl Östlund (Employment), Stojan Arnerstål och Sofia Bergenstråhle (IP), Mika Jordan (IT & GDPR), Christoffer Nordin (Regulatory) Fredrika Hjelmberg and Carla Zachariasson (Commercial Agreements) Tove Lövgren Frisk (Compliance) and Carl Bruneheim (Project assistant).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025